Advancing equitable implementation of genomic medicine in nephrology
Advancing equitable implementation of genomic medicine in nephrology
批准号:
10591982
负责人:
Hila Milo Rasouly
金额:
$12.89万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2027-08-31
关键词:
AddressAdoptionCharacteristicsChronic Kidney FailureClinicClinicalCommunication ResearchCommunitiesCompetenceDataDevelopmentDoctor of PhilosophyEducational BackgroundEnsureEnvironmentFeasibility StudiesFoundationsFundingFutureGenesGeneticGenetic CounselingGenetic DeterminismGenetic TranslationGenomic medicineGenomicsGoalsGrantGuidelinesHealth educationHealthcare SystemsHigh PrevalenceInternationalInterventionInterviewInvestmentsKidneyKidney DiseasesKnowledgeLeadLearningMeasuresMedical GeneticsMentored Research Scientist Development AwardMentorsMentorshipMethodsNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyOnline SystemsOutcomeParticipantPathologyPatientsPopulationProspective StudiesProviderQualitative ResearchResearchResearch MethodologyResearch PersonnelResearch PriorityResearch TrainingResourcesRespondentSeedsStrategic PlanningSurveysTestingTrainingTranslatingTranslationsUnited States National Institutes of HealthUniversitiesarmclinical careclinical practicecohortcomputer human interactiondesigndissemination researchefficacy trialethical legal social implicationethnic minorityexperiencefeasibility testingfuture implementationgenetic counselorgenetic disorder diagnosisgenetic testinghealth communicationhealth disparityhealth equityhealth literacyimplementation frameworkimplementation researchimplementation scienceimplementation strategyimprovedinnovationkidney biopsyliteracynovelpatient engagementpatient screeningpersonalized carepilot testpoint of carepost-doctoral trainingpractice settingprecision medicinepreventprogramsprospectivepublic health relevanceracial and ethnicracial minorityscreeningsecondary outcomeskillssocial determinantssocioeconomicsstatisticssymposiumtheoriestooluptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is an immense national investment in Precision Medicine, however fulfillment of its promises depends on
broad utilization of genetic testing among nephrologists and patients, many of whom are from marginalized
racial/ethnic minorities. Research demonstrates that genetic forms of kidney disease are relatively prevalent,
and their identification can personalize care, yet genetic testing is not part of standard clinical care in nephrology.
This K01 proposes to identify the barriers to genetic testing in nephrology at the patient, clinician, and healthcare
system levels, and to develop and test possible facilitators. I will use a mixed methods design to collect nuanced,
currently unavailable, data on these issues with the goal of informing future implementation guidelines. Aim 1
will assess the rate of adoption of genetic testing in nephrology, and the barriers, facilitators, and acceptability
of potential implementation strategies to accelerate the adoption of genetic testing in nephrology. To address
the low confidence of nephrologists in genetics—a key barrier in effort to translate knowledge from labs to the
clinics—in Aim 2, I will use participatory design to develop a toolbox with the input of both patients and
nephrologists. The toolbox will include (i) a self-paced course in clinical renal genetics and external resources, (ii)
patient-facing materials with infographics, and (iii) a genetic literacy screen for patients. In Aim 3, I will assess the
toolbox’s potential by pilot testing it with nephrologists. This K01 will inform future efficacy trials and lay the
foundations for future research on interventions to ensure equitable access to genetic testing. Candidate: I hold
a Master in Genetic Counseling, a PhD in genetics and genomics and have a post-doctoral training in renal
genomics. To advance the implementation of genomic medicine in nephrology, there is a need for researchers
with combined expertise in genetics, nephrology, implementation science, health communication, health equity
research, and ethical, legal, and social Implications (ELSI) of genomics. My goal is to develop an independent
research program focusing on the novel field of “equitable implementation of genomic medicine in
nephrology”. During the K01’s training period, I will: (1) Develop expertise in the theoretical frameworks in
implementation science, (2) Become proficient in ELSI and health equity research, (3) Develop expertise in
qualitative research methods, (4) Refine my expertise in survey design, (5) Learn health communication research
tools and (6) Transition to independence. Environment: To guide and support my research and training goals,
I have assembled a strong mentorship team of experts in nephrology and renal genetics (Dr Gharavi, primary
mentor), translation of genomics research into clinical practice (Dr Rahm, co-mentor), implementation science
(Dr Moise, co-mentor), Equity and ELSI research (Dr Sabatello, co-mentor), health communication and
infographics (Dr Bakken, Advisor), and statistics (Dr Ionita-Laza, Advisor). The research will be conducted at
Columbia University, which will give me access to extensive research resources and training to help me
successfully transition to independence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing equitable implementation of genomic medicine in nephrology
-
批准号:10701851
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2022
-
负责人:Hila Milo Rasouly
-
依托单位:
海外基金